U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
6849168491Sirolimus With Cyclophosphamide and Topotecan for Pediatric/Adolescent Relapsed and Refractory Solid TumorsActive, not recruitingNo Results AvailableMalignant Solid Tumor|Childhood Solid TumorDrug: Sirolimus, Cyclophosphamide, Topotecanhttps://ClinicalTrials.gov/show/NCT01670175
6849268492On-label tReatment With Intravitreal Aflibercept injectiOn for Patients With Persistent Pigment epitheliaL Detachments in Neovascular Age Related Macular Degeneration (AMD)Active, not recruitingNo Results AvailableAge Related Macular Degeneration|Pigment Epithelial DetachmentDrug: Aflibercepthttps://ClinicalTrials.gov/show/NCT01670162
6849368493Rifaximin for Preventing Relapse of Clostridium Associated DiarrhoeaRecruitingNo Results AvailableClostridium Difficile InfectionDrug: Rifaximin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01670149
6849468494Pharmacokinetics of Sildenafil in Premature InfantsRecruitingNo Results AvailablePersistent Pulmonary Hypertension of the NewbornDrug: 1 dose of sildenafilhttps://ClinicalTrials.gov/show/NCT01670136
6849568495Development of a Personalized Real-time Intervention for Bipolar DisorderCompletedNo Results AvailableBipolar DisorderBehavioral: Personalized Real-Time Intervention for Stabilizing Moodhttps://ClinicalTrials.gov/show/NCT01670123
6849668496Pasireotide LAR in Severe Polycystic Liver DiseaseRecruitingNo Results AvailableSomatostatin Analogs|Polycystic Liver Disease|Autosomal Dominant Polycystic Kidney Disease|Autosomal Dominant Polycystic Liver DiseaseDrug: Pasireotide LAR|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01670110
6849768497Dexamethasone Dyspnea StudyActive, not recruitingNo Results AvailableAdvanced Cancers|Hematologic Disorder|Solid TumorsDrug: Dexamethasone|Drug: Placebo|Behavioral: Questionnaires|Device: Spirometer|Other: Phone Callshttps://ClinicalTrials.gov/show/NCT01670097
6849868498Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous LeukemiaWithdrawnNo Results AvailableB-cell Adult Acute Lymphoblastic Leukemia|Blastic Phase Chronic Myelogenous Leukemia|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia|Untreated Adult Acute Lymphoblastic LeukemiaDrug: nilotinib|Biological: rituximab|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: vincristine sulfate|Drug: methotrexate|Drug: cytarabine|Drug: prednisone|Drug: mesna|Drug: dexamethasone|Drug: leucovorin calciumhttps://ClinicalTrials.gov/show/NCT01670084
6849968499A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With SchizophreniaTerminatedNo Results AvailableSchizophreniaDrug: Paliperidone extended-release|Drug: Risperidone immediate-releasehttps://ClinicalTrials.gov/show/NCT01670071
6850068500Pattern Of Use Of Belatacept In US Transplant RecipientsActive, not recruitingNo Results AvailableKidney Transplantation: Transplantation, Kidneyhttps://ClinicalTrials.gov/show/NCT01670058
6850168501A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid ArthritisCompletedNo Results AvailableRheumatoid Arthritishttps://ClinicalTrials.gov/show/NCT01670045
6850268502Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in ImpetigoCompletedNo Results AvailableImpetigoDrug: Experimental: CD07223 1.5 % Topical Gel BID|Drug: Experimental: CD07223 1.5% Topical Gel TID|Drug: Placebo Comparator: CD07223 vehicle gel BID|Drug: Placebo Comparator: CD07223 vehicle gel TIDhttps://ClinicalTrials.gov/show/NCT01670032
6850368503Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for DepressionActive, not recruitingNo Results AvailableMajor Depressive Disorder Without Psychotic FeaturesDrug: Asenapine 5-20 mg daily|Drug: Placebo 1-4 tablets dailyhttps://ClinicalTrials.gov/show/NCT01670019
6850468504[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT01670006
6850568505Factors Predictive of Adverse Postoperative Outcomes in Children Undergoing TonsillectomyEnrolling by invitationNo Results AvailableTonsillectomy Postoperative Adverse Eventshttps://ClinicalTrials.gov/show/NCT01669993
6850668506Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Community Acquired Pneumonia (CABP)CompletedNo Results AvailableInfections|PneumoniaDrug: Ceftaroline fosamil|Drug: IV Ceftriaxone and Vancomycinhttps://ClinicalTrials.gov/show/NCT01669980
6850768507The Role of Intravenous (IV) Lidocaine in the Management of Chronic Neuropathic Pain of Peripheral Nerve OriginRecruitingNo Results AvailableNeuropathic PainDrug: Lidocaine|Drug: Diphenhydraminehttps://ClinicalTrials.gov/show/NCT01669967
6850868508Determination of Optimum Age for DXA Screening for Osteoporosis in HIV - The Probono 1 StudyCompletedNo Results AvailableOsteoporosis|Fractures|HIV Infectionhttps://ClinicalTrials.gov/show/NCT01669954
6850968509Efficacy of Intermittent Screening and Treatment or Intermittent Preventive Treatment (IPT) With Dihydroartemisinin-Piperaquine, Versus IPT With Sulfadoxine-Pyrimethamine for the Control of Malaria in Pregnancy in KenyaActive, not recruitingNo Results AvailablePregnancy|MalariaDrug: IPTp-SP|Drug: IPTp-DP|Drug: ISTp-DPhttps://ClinicalTrials.gov/show/NCT01669941
6851068510Anti-hypertensive Medication Dosing Regimen in Effective Blood Pressure ControlCompletedNo Results AvailableHypertensionDrug: Anti-hypertensive Medication -https://ClinicalTrials.gov/show/NCT01669928
6851168511A Large Randomized Trial of Vitamin D, Omega-3 Fatty Acids and Cognitive DeclineEnrolling by invitationNo Results AvailableCognitive DeclineDietary Supplement: vitamin D3|Drug: omega-3 fatty acids (fish oil)|Dietary Supplement: Vitamin D3 placebo|Dietary Supplement: Fish oil placebohttps://ClinicalTrials.gov/show/NCT01669915
6851268512An Observational Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid ArthritisCompletedNo Results AvailableRheumatoid Arthritishttps://ClinicalTrials.gov/show/NCT01669902
6851368513A Non-Drug Study on the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's SyndromeCompletedNo Results AvailableHealthy Volunteer, Autistic Disorder, Asperger's Syndromehttps://ClinicalTrials.gov/show/NCT01669889
6851468514Study to Evaluate Dietary Supplementation With a Version of Anatabloc(R) in Subjects With Alzheimer's DiseaseTerminatedNo Results AvailableAlzheimer DiseaseDietary Supplement: Anatabloc(R)|Dietary Supplement: Placebohttps://ClinicalTrials.gov/show/NCT01669876
6851568515Extracorporeal Membrane Oxygenation (ECMO) in Non-intubated Patients With Acute Respiratory Distress Syndrome (ARDS)CompletedHas ResultsARDSDevice: ECMO|Procedure: ECMO in non-intubated patientshttps://ClinicalTrials.gov/show/NCT01669863
6851668516Clipped Versus Handsewn Arteriovenous Fistula AnastomosisTerminatedNo Results AvailableArteriovenous Fistula Complications and FailureDevice: Clipped anastomosis|Procedure: Handsewn anastomosishttps://ClinicalTrials.gov/show/NCT01669850
6851768517An Efficiency/Safety Study of Surgical Tissue Glue to Treat Inguinal HerniasRecruitingNo Results AvailableInguinal HerniaDevice: Mesh fixation with surgical tissue gluehttps://ClinicalTrials.gov/show/NCT01669837
6851868518Pharmacy Based Pharmacoepidemiological Observational Study With Aspirin Protect 100 mgCompletedNo Results AvailableAspirin|Drug Safety|Effects, LongtermDrug: Acetylsalicylic acid (Aspirin, BAYE4465)https://ClinicalTrials.gov/show/NCT01669824
6851968519Compare D961H 20 mg Bid and 20 mg qd in Patients With Refractory Reflux Esophagitis (Inflammation of Lower Esophagus)CompletedHas ResultsRefractory Reflux EsophagitisDrug: Esomeprazole (D961H) twice daily|Drug: Esomeprazole (D961H) once dailyhttps://ClinicalTrials.gov/show/NCT01669811
6852068520BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian CancerRecruitingNo Results AvailableOvarian Cancer|Fallopian Tube Cancer|Peritoneal CancerDrug: BIBF 1120https://ClinicalTrials.gov/show/NCT01669798

* Görseller ve İçerik tekif hakkına sahip olabilir